Literature DB >> 8679567

Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.

E Carmona1, E Dufour, C Plouffe, S Takebe, P Mason, J S Mort, R Ménard.   

Abstract

The cathepsin L propeptide (phcl-2) was expressed in Saccharomyces cerevisiae using a human procathepsin L/alpha-factor fusion construct containing a stop codon at position -1 (the C-terminal amino acid of the proregion). Since the yield after purification was very low, the cathepsin L propeptide was also obtained by an alternate procedure through controlled processing of an inactive mutant of procathepsin L (Cys25Ser/Thrl10Ala) expressed in Pichia pastoris, by small amounts of cathepsin L. The peptide resulting from the cleavage of the proenzyme (phcl-1) was then purified by HPLC. The purified propeptides were characterized by N-terminal sequencing and mass spectrometry and correspond to incomplete forms of the proregion (87 and 81 aa for phcl-1 and phcl-2 respectively, compared to 96 aa for the complete cathepsin L propeptide). The two peptides were found to be potent and selective inhibitors of cathepsin L at pH 5.5, with Ki values of 0.088 nM for phcl-1 and 0.66 nM for phcl-2. The Ki for inhibition of cathepsin S was much higher (44.6 nM with phcl-1), and no inhibition of cathepsin B or papain could be detected at up to 1 microM of the propeptide. The inhibitory activity was also found to be strongly pH-dependent. Two synthetic peptides of 75 and 44 aa corresponding to N-terminal truncated versions of the propeptide were also prepared by solid phase synthesis and displayed Ki values of 11 nM and 2900 nM, respectively, against cathepsin L. The data obtained for the 4 propeptide derivatives of various lengths indicate that the first 20 residues in the N-terminal region of the propeptide are more important for inhibition than the C-terminal region which contributes little to the overall inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679567     DOI: 10.1021/bi952736s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  A single mutation in the carboxy terminus of reovirus outer-capsid protein sigma 3 confers enhanced kinetics of sigma 3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in sigma 3 structure.

Authors:  Gregory J Wilson; Emma L Nason; Charles S Hardy; Daniel H Ebert; J Denise Wetzel; B V Venkataram Prasad; Terence S Dermody
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

Review 3.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

4.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.

Authors:  R Coulombe; P Grochulski; J Sivaraman; R Ménard; J S Mort; M Cygler
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 5.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

6.  The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions.

Authors:  Guido Kaulmann; Gottfried J Palm; Klaus Schilling; Rolf Hilgenfeld; Bernd Wiederanders
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

7.  Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.

Authors:  Ana C Figueiredo; Daniele de Sanctis; Ricardo Gutiérrez-Gallego; Tatiana B Cereija; Sandra Macedo-Ribeiro; Pablo Fuentes-Prior; Pedro José Barbosa Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

8.  Autocatalytic processing of procathepsin B is triggered by proenzyme activity.

Authors:  Jerica Rozman Pungercar; Dejan Caglic; Mohammed Sajid; Marko Dolinar; Olga Vasiljeva; Urska Pozgan; Dusan Turk; Matthew Bogyo; Vito Turk; Boris Turk
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

9.  Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli.

Authors:  Benedykt Wladyka; Katarzyna Puzia; Adam Dubin
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.

Authors:  J S Mort; M C Magny; E R Lee
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.